C07K 1 - General processes for the preparation of peptides

Patents for C07K 1 - General processes for the preparation of peptides (51,718)
11/2001
11/21/2001	EP1154827A1 Purification of biological substances
11/21/2001	EP0707594B1 Separation of proteins
11/21/2001	EP0675898B1 Use of molecularly imprinted polymers for stereo- and/or regioselective synthesis
11/21/2001	CN1323316A 丙型肝炎三肽抑制剂 Tripeptide inhibitor of hepatitis C
11/21/2001	CN1323313A Process for the preparation of resin-bound cyclic peptides
11/21/2001	CN1322761A Animal hematoglobin and its extraction process and use
11/21/2001	CN1322759A Composition for stimulating megacaryocyte growth and differentiation and process thereof
11/21/2001	CN1322731A Simple high-density lipoprotein separating process from serum and the prepn of its subcomponent reagent kit
11/21/2001	CN1075078C Producing process of stem cell factor
11/20/2001	US6320025 Apparatus for efficient generation of preferential peptide sequences
11/20/2001	US6319896 Adding aqueous solution of charged polymer to solution of purified protein to reduce intermolecular or intramolecular interactions between the positively and negatively charged domains whereby solubility of protein is increased
11/20/2001	US6319693 Cloning of chicken anemia virus DNA
11/20/2001	US6319668 Target molecules with linking to matrix, imprinting an optical read symbol, programming a remote memory and repeating until synthesis is complete
11/20/2001	US6319472 Stacked, multilayer, electronically reconfigurable; for the transport and/or analysis of biological materials like nucleic acids, biological pathogens and toxins
11/20/2001	CA2224086C Conformationally-restricted combinatorial library composition and method
11/20/2001	CA2142557C Cytotoxic factor linked with multiple sclerosis and detection and quantitation thereof
11/15/2001	WO2001086296A2 Highly multiplexed reporter carrier systems
11/15/2001	WO2001086037A1 Crystal growth apparatus and crystal growth method
11/15/2001	WO2001085950A2 Genes of the 1-desoxy-d-xylulose biosynthesis path
11/15/2001	WO2001085906A2 Catalytically active peptides
11/15/2001	WO2001085796A2 Use of inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumour formation and/or vascular leakage
11/15/2001	WO2001085790A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
11/15/2001	WO2001085759A1 Separation of avian antibodies
11/15/2001	WO2001085757A2 Purification of protein inclusion bodies by crossflow microfiltration
11/15/2001	WO2001085756A2 Site-selective acyl transfer
11/15/2001	WO2001038227A3 A method for anion-exchange adsorption and anion-exchangers
11/15/2001	WO2001036001A3 Interferon gamma conjugates
11/15/2001	WO2001015737A3 Method for coupling molecules
11/15/2001	WO2000026370A9 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/15/2001	US20010041795 Polymeric separation media
11/15/2001	US20010041703 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair
11/15/2001	DE10022258A1 Purification and/or concentration of protein inclusion bodies in solution, by passing the solution tangentially across semipermeable membrane formed from intersecting longitudinal and transverse fibers
11/15/2001	DE10021688A1 New DNA sequences involved in isoprenoid biosynthesis, useful in screening for compounds with e.g. antimicrobial and herbicidal activity
11/15/2001	CA2408571A1 Mammalian receptor proteins; related reagents and methods
11/15/2001	CA2407955A1 Genes of the 1-desoxy-d-xylulose biosynthesis path
11/15/2001	CA2407858A1 Use of inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumour formation and/or vascular leakage
11/15/2001	CA2405694A1 Separation of avian antibodies
11/14/2001	EP1153282A2 Method and devices for detecting optical properties, especially luminescence reactions and refraction behaviour of molecules which are directly or indirectly bound on a support
11/14/2001	EP1053355B1 Pna and dna conjugates and methods for preparation thereof
11/14/2001	EP0912604B1 Improved chemical process for preparing amide derivatives of antibiotic A 40926
11/14/2001	EP0688360B1 Bone stimulating factor
11/14/2001	EP0652900B1 Thrombin inhibitors
11/14/2001	CN1322211A Process for eliminating N-terminal methionine
11/14/2001	CN1321743A Yak blood superoxide dismutase and its extraction purification process and application
11/14/2001	CN1321640A Method for separating and recovery of protein and isoflavone from plant raw material
11/13/2001	US6316595 PNA synthesis using a base-labile amino protecting group
11/13/2001	US6316153 Free-form fabricaton using multi-photon excitation
11/13/2001	US6315953 Devices for molecular biological analysis and diagnostics including waveguides
11/13/2001	US6315900 Static separation method using non-porous cellulose beads
11/08/2001	WO2001083804A2 A method for improving recombinant protein stability and solubility
11/08/2001	WO2001083770A2 Lipolytic enzyme variant
11/08/2001	WO2001083761A1 Laccase mutants
11/08/2001	WO2001083559A2 Production and use of protein variants having modified immunogenecity
11/08/2001	WO2001083527A2 Glucagon antagonists
11/08/2001	WO2001083524A2 Rna metabolism proteins
11/08/2001	WO2001083522A2 Growth factor modified protein matrices for tissue engineering
11/08/2001	WO2001083521A2 Reductive alkylation process on glycopeptides
11/08/2001	WO2001083515A2 Simulated activity of protein a displayed by ligands attached to a cellulose bead surface
11/08/2001	WO2001083439A2 Novel $g(y) crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
11/08/2001	WO2001082971A2 Cyclodextrin containing glycopeptide antibiotic compositions
11/08/2001	WO2000061194A3 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics
11/08/2001	WO2000046238A8 Volatilizable solid phase supports for compound synthesis
11/08/2001	WO2000044767A3 Method for drying protein crystals
11/08/2001	WO2000001841A3 Hyaluronic acid mimics and methods related thereto
11/08/2001	US20010039480 Apparatus and method for automated protein design
11/08/2001	US20010039479 Three-dimensional model of a Fc region of an IgE antibody and uses thereof
11/08/2001	US20010039258 Exposing biologically active agent to complexing perturbant to reversibly transform biologically active agent to intermediate state and to form a subcutaneously deliverable supramolecular complex, subcutaneously administering complex
11/08/2001	US20010039043 Recovering a target protein having milk clotting activity from an aqueous medium by binding the protein to a solid support matrix having an alkylamine ligand covalently bonded to it; elution; efficiency; chromatography
11/08/2001	US20010039020 Bead distributor detector
11/08/2001	US20010039011 Complexing; biosynthesis
11/08/2001	CA2726789A1 Cyclodextrin containing glycopeptide antibiotic compositions
11/08/2001	CA2414775A1 A method and device for improving protein stability and solubility
11/08/2001	CA2407435A1 Rna metabolism proteins
11/08/2001	CA2407276A1 Simulated activity of protein a displayed by ligands attached to a cellulose bead surface
11/08/2001	CA2406621A1 Protein variants having modified immunogenicity
11/07/2001	EP1151299A1 Method of site specific labeling of proteins and uses therefor
11/07/2001	EP1151117A1 Intein-mediated protein ligation of expressed proteins
11/07/2001	EP1151007A1 A method for producing a preparation based on fibrinogen and fibronectin as well as protein compositions obtainable according to this method
11/07/2001	EP1150998A1 Process for the preparation of cyclic tetrapeptide derivatives
11/06/2001	US6313274 Subjecting to ultraviolet radiation to reduce some disulfide bonds and generate thiol moieties; reacting with antibody, ultraviolet radiation to reduce some disulfide bonds and reacting with chemical; labeling antibodies
11/06/2001	US6313264 Effector proteins of Rapamycin
11/06/2001	US6313102 Stabilized dry composition comprising therapeutic agent susceptible to maillard reaction, further comprising reducing carbohydrate as stabilizer for therapeutic agent and inhibitor of maillard reaction
11/06/2001	US6313092 Method for increasing the electrotransport flux of polypeptides
11/06/2001	US6312923 Method for expression of heterologous proteins in yeast
11/06/2001	US6312910 Multistage electromagnetic separator for purifying cells, chemicals and protein structures
11/01/2001	WO2001081367A2 Purification of polypeptides
11/01/2001	WO2001081365A2 Metal chelating compositions
11/01/2001	WO2001029066A3 Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them
11/01/2001	US20010036629 Sequencing of surface immobilized polymers utilizing microfluorescence detection
11/01/2001	CA2406721A1 Purification of polypeptides
10/2001
10/31/2001	EP1150121A2 Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease
10/31/2001	EP1149288A1 Process for pan-genomic determination of macromolecular atomic structures
10/31/2001	EP1149163A2 Human serum albumin
10/31/2001	EP1148945A1 New hydrophobic polymer comprising fluorine moieties
10/31/2001	EP1148942A1 Flow-through device and its use for binding polymers to membrane surfaces
10/31/2001	EP1148779A2 Expression of secreted human alpha-fetoprotein in transgenic animals
10/31/2001	EP0832097B1 A system and method for the modification and purification of peptides
10/31/2001	EP0815141B1 Antibodies active against a fusion polypeptide comprising a histidine portion
10/31/2001	EP0779896B1 New process for the production of biologically active protein (tgf)
10/31/2001	EP0775159B1 Novel process for the production of biologically active dimeric protein

1 ... 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 ... 518